BICO Group AB (publ) (BICO.ST)
SEK 34.84
(5.07%)
SEK 34.84
(5.07%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2022 | 1.75 Billion SEK | 13.37% |
| 2021 | 1.54 Billion SEK | 3131.76% |
| 2020 | 47.91 Million SEK | 7885.33% |
| 2019 | 600 Thousand SEK | 0.0% |
| 2018 | 600 Thousand SEK | -77.78% |
| 2017 | 2.7 Million SEK | -10.0% |
| 2016 | 3 Million SEK | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 Q3 | 1.76 Billion SEK | -1.16% |
| 2023 Q1 | 1.77 Billion SEK | 1.01% |
| 2023 Q2 | 1.78 Billion SEK | 0.47% |
| 2022 Q1 | 1.58 Billion SEK | 2.04% |
| 2022 Q4 | 1.75 Billion SEK | 0.45% |
| 2022 Q3 | 1.74 Billion SEK | 0.42% |
| 2022 Q2 | 1.74 Billion SEK | 10.15% |
| 2022 FY | 1.75 Billion SEK | 13.37% |
| 2021 Q4 | 1.54 Billion SEK | 2.52% |
| 2021 Q1 | 110.7 Million SEK | 0.0% |
| 2021 FY | 1.54 Billion SEK | 3131.76% |
| 2021 Q2 | 1.48 Billion SEK | 1237.94% |
| 2021 Q3 | 1.51 Billion SEK | 1.97% |
| 2020 FY | 47.91 Million SEK | 7885.33% |
| 2020 Q3 | 47.91 Million SEK | 45.72% |
| 2020 Q1 | 26.96 Million SEK | 34.17% |
| 2020 Q2 | 32.88 Million SEK | 21.95% |
| 2019 Q2 | 600 Thousand SEK | 0.0% |
| 2019 Q1 | 600 Thousand SEK | 0.0% |
| 2019 Q3 | 600 Thousand SEK | 0.0% |
| 2019 FY | 600 Thousand SEK | 0.0% |
| 2019 Q4 | 20.09 Million SEK | 3249.0% |
| 2018 Q2 | 600 Thousand SEK | 0.0% |
| 2018 FY | 600 Thousand SEK | -77.78% |
| 2018 Q4 | 600 Thousand SEK | 0.0% |
| 2018 Q3 | 600 Thousand SEK | 0.0% |
| 2018 Q1 | - SEK | 0.0% |
| 2017 Q2 | 3 Million SEK | 0.0% |
| 2017 Q4 | - SEK | -100.0% |
| 2017 FY | 2.7 Million SEK | -10.0% |
| 2017 Q1 | 3 Million SEK | 0.0% |
| 2017 Q3 | 2.7 Million SEK | -10.0% |
| 2016 FY | 3 Million SEK | 0.0% |
| 2016 Q4 | 3 Million SEK | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Acarix AB (publ) | - SEK | -Infinity% |
| ADDvise Group AB (publ) | 1.45 Billion SEK | -20.497% |
| ADDvise Group AB (publ) | 1.45 Billion SEK | -20.497% |
| Arcoma AB | 1.92 Million SEK | -90994.966% |
| Bactiguard Holding AB (publ) | 42.3 Million SEK | -4049.293% |
| Boule Diagnostics AB (publ) | 57.7 Million SEK | -2942.288% |
| CellaVision AB (publ) | 28.66 Million SEK | -6024.058% |
| Clinical Laserthermia Systems AB (publ) | 223 Thousand SEK | -787074.888% |
| Chordate Medical Holding AB (publ) | - SEK | -Infinity% |
| C-Rad AB (publ) | 1.75 Million SEK | -100036.908% |
| Duearity AB (publ) | 2.94 Million SEK | -59607.483% |
| Dignitana AB (publ) | 6.07 Million SEK | -28785.963% |
| Episurf Medical AB (publ) | 2.3 Million SEK | -76221.739% |
| Getinge AB (publ) | 3.9 Billion SEK | 55.024% |
| Scandinavian Real Heart AB (Publ) | 6.35 Million SEK | -27531.388% |
| Iconovo AB (publ) | 4.9 Million SEK | -35674.129% |
| Integrum AB (publ) | 4.84 Million SEK | -36134.517% |
| Luxbright AB (publ) | 206.02 Thousand SEK | -851936.656% |
| Mentice AB (publ) | 2.14 Million SEK | -81775.0% |
| OssDsign AB (publ) | 214 Thousand SEK | -820180.374% |
| Paxman AB (publ) | 2.53 Million SEK | -69228.594% |
| Promimic AB (publ) | - SEK | -Infinity% |
| Qlife Holding AB (publ) | 3 Million SEK | -58335.419% |
| SciBase Holding AB (publ) | 4.17 Million SEK | -41905.264% |
| ScandiDos AB (publ) | - SEK | -Infinity% |
| Sectra AB (publ) | 19.2 Million SEK | -9040.804% |
| Sedana Medical AB (publ) | 1.01 Million SEK | -173358.498% |
| Senzime AB (publ) | 8.57 Million SEK | -20363.978% |
| SpectraCure AB (publ) | 4.39 Million SEK | -39822.675% |
| Stille AB | 38.06 Million SEK | -4511.464% |
| Vitrolife AB (publ) | 1.87 Billion SEK | 6.379% |
| Xvivo Perfusion AB (publ) | 21.16 Million SEK | -8192.314% |